HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers

Conclusion: Our finding that IBC cells are sensitive to HDAC6 inhibition provides a foundation to rapidly develop novel, efficient, and well-tolerated targeted therapy strategies for IBC patients.
Source: Breast Cancer Research - Category: Cancer & Oncology Authors: Source Type: research